Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Nuclear Medicine

Free Subscription 01.07.2024 1 Ann Nucl Med 1 Appl Radiat Isot 18 Clin Nucl Med 2 J Nucl Med 2 Nucl Med Commun 3 Phys Med Biol 2 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Nucl Med

1. OKUYAMA C, Higashi T, Ishizu K, Oishi N, et al
   New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map.
   Ann Nucl Med. 2024 Jun 22. doi: 10.1007/s12149-024-01956.
   PubMed         Abstract available
   
   

   
   Appl Radiat Isot

2. KANG KJ, Kim YG, Oh SJ, Won J, et al
   Determination of optimal injection dose in a small animal-dedicated positron emission tomography for non-human primate neurological studies.
   Appl Radiat Isot. 2024;211:111404.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

3. ROUSSEAU C, Metz R, Kerdraon O, Ouldamer L, et al
   Pilot Feasibility Study: 18F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS).
   Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005338.
   PubMed         Abstract available
   
   
4. KOZIARZ A, Koziarz F, Shen R, Gopee-Ramanan P, et al
   Diagnostic Accuracy of SPECT for Mild Traumatic Brain Injury: A Systematic Review and Meta-analysis.
   Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005328.
   PubMed         Abstract available
   
   
5. ZHANG Z, Guo S, Cheng C, Cao K, et al
   Integrated 68Ga-FAPI-04 PET/MR in Pancreatic Cancer: Prediction of Tumor Response and Tumor Resectability After Neoadjuvant Therapy.
   Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005300.
   PubMed         Abstract available
   
   
6. OLDAN JD, Landman PG, Schroeder JA, Khandani AH, et al
   FDG PET in a Patient on a GLP-1 Agonist/Insulin Secretagogue.
   Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005318.
   PubMed         Abstract available
   
   
7. GIROD BJ, Nguyen NC
   Prostatic Utricle Cysts as a Potential Pitfall in PSMA PET/CT Interpretation.
   Clin Nucl Med. 2024 Jun 20. doi: 10.1097/RLU.0000000000005340.
   PubMed         Abstract available
   
   
8. YANG L, Dong Z, Wei L, Chen F, et al
   Simple Pulmonary Eosinophilia Mimicking Lung Metastases on 18F-FDG PET/CT.
   Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005339.
   PubMed         Abstract available
   
   
9. SAHIN O, Aydin Z, Kerimoglu U, Karakasoglu CC, et al
   18F-FDG PET/CT Findings of a Patient With Stercoral Colitis.
   Clin Nucl Med. 2024 Jun 20. doi: 10.1097/RLU.0000000000005331.
   PubMed         Abstract available
   
   
10. HU S, Lan X, Cao W, Gao Z, et al
    Unusual Achalasia Presentation Detected on 131I SPECT/CT in a Papillary Thyroid Carcinoma Patient.
    Clin Nucl Med. 2024 Jun 20. doi: 10.1097/RLU.0000000000005337.
    PubMed         Abstract available
    
    
11. BEYTUR MF, Alcin G, Cin S, Ergul N, et al
    Radiation Therapy-Induced Fibrous Histiocytoma, Mimicking Local Recurrence and Detected by 18F-FDG PET/CT in a Patient With Breast Cancer.
    Clin Nucl Med. 2024 Jun 20. doi: 10.1097/RLU.0000000000005320.
    PubMed         Abstract available
    
    
12. DING J, Zhao J, Chen X, You Z, et al
    The Added Value of Contrast-Enhanced 68Ga-FAPI-04 PET/MRI Over 18F-FDG PET/CT in Hepatocellular Carcinoma.
    Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005342.
    PubMed         Abstract available
    
    
13. ENGKEBOLLE C, Elisabeth Engelmann B, Scheie D, Fugleholm K, et al
    Intracranial Mesenchymal Tumor, FET-CREB Fusion Positive, Evaluated With 18F-FET and 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005346.
    PubMed         Abstract available
    
    
14. KUMAR S, Mittal BR, Kumar R, Singh H, et al
    Incidental Detection of Lipomatous Hypertrophy of the Interventricular Septum on FDG PET/CT.
    Clin Nucl Med. 2024 Jun 20. doi: 10.1097/RLU.0000000000005336.
    PubMed         Abstract available
    
    
15. CUI F, Su M, Tian R, Li Q, et al
    Cavernous Sinus Metastasis From Laryngeal Cancer Identified by 18F-FDG PET/MR.
    Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005350.
    PubMed         Abstract available
    
    
16. ZHAO X, Dai M, Li N, Zhang J, et al
    Brain Nocardiosis Mimicking Intracerebral Invasion on 68Ga-Pentixafor PET/CT in a Patient With Multiple Myeloma.
    Clin Nucl Med. 2024 Jun 21. doi: 10.1097/RLU.0000000000005351.
    PubMed         Abstract available
    
    
17. ABDLKADIR AS, Almasri N, Estrada E, Fani Bozkurt M, et al
    18F-FDG PET/CT Unveils Coexistent Myelomatous Hepatosplenic and Thyroid Cartilage Involvement: A Rare Presentation in Multiple Myeloma.
    Clin Nucl Med. 2024 Jun 25. doi: 10.1097/RLU.0000000000005326.
    PubMed         Abstract available
    
    
18. MOREAU A, Pretet V, Kryza D
    False-Positive Bone Lesion With Different PET/CT Tracers: Beyond Thrombosis, Be Aware of Any Collateral Circulation.
    Clin Nucl Med. 2024 Jun 25. doi: 10.1097/RLU.0000000000005319.
    PubMed         Abstract available
    
    
19. SINGH P, Kandula KK, Patel RK, Parida GK, et al
    Incidental 68Ga-PSMA Uptake in the Benign Enchondroma-A Rare Finding on 68Ga-PSMA PET/CT.
    Clin Nucl Med. 2024 Jun 27. doi: 10.1097/RLU.0000000000005361.
    PubMed         Abstract available
    
    
20. CHEN BL, Huang WS, Yu JQ, Yan CS, et al
    Massive Hepatocellular Carcinoma Combined With Giant Uterine Fibroid on 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jun 27. doi: 10.1097/RLU.0000000000005356.
    PubMed         Abstract available
    
    

    
    J Nucl Med

21. LAVERDIERE I, Matte G, Darveau M, Beauregard JM, et al
    Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehensive Pharmaceutical Care.
    J Nucl Med. 2024 Jun 21:jnumed.124.267603. doi: 10.2967/jnumed.124.267603.
    PubMed        
    
    
22. COMBET-CURT V, Buchalet C, Malicot KL, Lemanski C, et al
    Prognostic Value of (18)F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE.
    J Nucl Med. 2024 Jun 27:jnumed.124.267626. doi: 10.2967/jnumed.124.267626.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

23. LITTLE D, Graham R, Redman S
    BNMS guidelines for Nuclear Medicine Events and Learning Meetings: principles for departmental learning from unforeseen events.
    Nucl Med Commun. 2024 Jun 27. doi: 10.1097/MNM.0000000000001876.
    PubMed        
    
    
24. CHANDEKAR KR, Satapathy S, Singh H, Kumar R, et al
    Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis - a head-to-head comparison of the radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11.
    Nucl Med Commun. 2024 Jun 27. doi: 10.1097/MNM.0000000000001874.
    PubMed         Abstract available
    
    

    
    Phys Med Biol

25. KONIAR H, Wharton L, Ingham A, Rodriguez-Rodriguez C, et al
    In vivoquantitative SPECT imaging of actinium-226: feasibility and proof-of-concept.
    Phys Med Biol. 2024 Jun 26. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
26. HAMMERSEN NL, Jentzen W, Stawitzki F, Herrmann K, et al
    PET quantification performance of the oversize-volume-of-interest approach in the context of tumour dosimetry in radionuclide therapy planning.
    Phys Med Biol. 2024 Jun 26. doi: 10.1088/1361-6560.
    PubMed         Abstract available
    
    
27. LAWLESS M, Byrns K, Bednarz BP, Meudt J, et al
    Feasibility of identifying proliferative active bone marrow with fat fraction MRI and multi-energy CT.
    Phys Med Biol. 2024;69.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

28. MAHAJAN S, Gavane S, Pandit-Taskar N
    Targeted Radiopharmaceutical Therapy for Bone Metastases.
    Semin Nucl Med. 2024 Jun 26:S0001-2998(24)00047.
    PubMed         Abstract available
    
    
29. DULLEA A, O'Sullivan L, O'Brien KK, Carrigan M, et al
    Diagnostic Accuracy of (18)F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews.
    Semin Nucl Med. 2024 Jun 20:S0001-2998(24)00044.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.